CRLComplete Response Letter
Complete Response Letter Delcath Systems, Incorporated (Sep 12, 2013)
FDA's complete response letter contains source-text evidence related to Clinical efficacy and substantial evidence, Device constituent and human factors, Labeling, packaging, and proprietary name, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• HEPZATO
